Live chat

RSV

BD Veritor™ Plus System

Respiratory Syncytial Virus (RSV) rapid antigen testing

 

Effectively test for RSV

Viral respiratory tract infections are responsible for widespread disease.¹ Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRI) in young children in both the developed and developing worlds²⁻³.

BD Veritor™ Plus System for RSV

The BD Veritor™ Plus System for Rapid Detection of RSV is a digital immunoassay (DIA) that qualitatively detects RSV fusion protein. There are two test kits available: the CLIA-waived test kit detects RSV fusion protein in infants and pediatric patients under the age of 6 years suspected of having RSV by their healthcare provider; the laboratory kit detects RSV fusion protein in patients up to 20 years of age who are suspected of having RSV by their healthcare provider.

The system offers one-button functionality for workflow flexibility, allowing health care providers to confidently use the Analyzer.  

Clock icon

Fast, reliable results in as few as 11 minutes⁴⁻⁵

BD Veritor Plus Analyzer icon

Two analysis options to optimize workflow

Rapid RSV test clinical performance data

RSV is a common virus, and can spread rapidly, especially among children²⁻³.

Comparison of BD Veritor™ System for Rapid Detection of RSV Test to viral cell culture.

 

In the chart below, data shows that, when compared to an accepted standard method, the BD Veritor™ System has a high Sensitivity rate (sensitivity measures the ability of the test to appropriately make a positive identification) and fewer false negatives⁴⁻⁵. In addition, data shows a high Specificity rate (specificity measures the ability of the test to properly identify the absence of the test target) and fewer false positives⁴⁻⁵.

Specimen Type: Nasopharyngeal Swab (NPS)⁴⁻⁵

88.4%

Sensitivity

(95% C.I 82.8-92.4%)
98.3%

Specificity

(95% C.I 96.8-99.7%)

Reference method : Viral Cell Culture

Sensitiivity : 88.4% (95% CI: 82.8-92.4%)

Specificity : 98.3% (95% CI: 96.8-99.1%)

Specimen Type: Nasal Wash
(NPWA)⁴⁻⁵

91.6%

Sensitivity

(95% C.I 86.3-94.9%)
94.5%

Specificity

(95% C.I 91.2-96.7%)

Reference method : Viral Cell Culture

Sensitiivity : 91.6% (95% C.I 86.3-94.9%)

Specificity : 94.5% (95% C.I 91.2-96.7%)

Summary of the performance of the BD Veritor™ System for Rapid Detection of RSV Test compared to viral cell culture by specimen type, all sites

NPS
VIRAL CELL CULTURE

BD Veritor TM

  P N Total
P 153 9 162
N 20 524 544
Total 173 533 706

NPWA
VIRAL CELL CULTURE

BD Veritor TM

  P N Total
P 152 15 167
N 14 259 273
Total 166 274 440

Explanation of Terms:  

Sensitivity: Ability of the test to properly identify the test target when it is present, compared to an accepted standard method (viral culture).

Specificity: Ability of the test to properly identify when the test target is not present, compared to an accepted standard method (viral culture).

P: Positive
N: Negative
C.I.: Confidence Interval

RSV assay

BD Veritor™ Plus System ordering and reimbursement

As your facility continues to provide valuable rapid diagnostic testing, you may need to reorder. Please click here for more information.

REFERENCES

  1. Vaccine Knowledge Project: http://vk.ovg.ox.ac.uk/rsv. Accessed December 19, 2018
  2. Nair, Harish et. al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010 May 1;375(9725):1500-2
  3. CDC: https://www.cdc.gov/rsv/about/symptoms.html
  4. BD Veritor System for Rapid Detection of Respiratory Syncytial Virus (RSV), CLIA-waived kit[ package insert], 8086098. Franklin Lakes, NJ: Becton, Dickinson and Company.
  5. BD Veritor System for Rapid Detection of Respiratory Syncytial Virus (RSV),laboratory kit [ package in-sert], 8086100. Franklin Lakes, NJ: Becton, Dickinson and Company.
Virus illustration